December 12, 2016 THE CELLEX FOUNDATION CONTRIBUTES WITH A DONATION TO THE PREDICT STUDY The Cellex contribution will allow Dr Jonel Trebicka to stay in Barcelona as a Visiting Professor for two years and to lead the new flagship Project of the EF Clif.

Dr Trebicka will be the Principal Investigator of the Predict Study, promoted by the EF Clif, which is meant to be fundamental to uncover mechanistic and pathophysiological processes associated with the development and clinical course of ACLF and to identify the precipitating events of ACLF.

The kick-off of the Predict Study is planned for early 2017. More than 40 centres of the EASL Clif Consortium from all around Europe will participate in it, with about 1,200 cirrhotic patients to be included.